Department of Internal Medicine, University of New Mexico School of Medicine , Albuquerque, New Mexico.
Department of Medicine, College of Medicine, Pennsylvania State University , Hershey, Pennsylvania.
Am J Physiol Cell Physiol. 2019 May 1;316(5):C753-C765. doi: 10.1152/ajpcell.00246.2018. Epub 2019 Mar 20.
A defective tight junction (TJ) barrier is a key pathogenic factor for inflammatory bowel disease. Previously, we have shown that autophagy, a cell survival mechanism, enhances intestinal epithelial TJ barrier function. Autophagy-related protein-6 (ATG6/beclin 1), a key protein in the autophagy pathway, also plays a role in the endocytic pathway. The constitutive role of beclin 1 in the intestinal TJ barrier is not known. In Caco-2 cells, beclin 1 was found to be coimmunoprecipitated with the TJ protein occludin and colocalized with occludin on the membrane. Treatment of Caco-2 cells with beclin 1 peptide [transactivating regulatory protein (Tat)-beclin 1] reduced TJ barrier function. Activation of beclin 1 increased occludin endocytosis and reduced total occludin protein level. In contrast, beclin 1 siRNA transfection enhanced Caco-2 TJ barrier function. In pharmacologic and genetic autophagy inhibition studies, the constitutive function of beclin 1 in the TJ barrier was found to be autophagy independent. However, de novo induction of autophagy with starvation or rapamycin prevented Tat-beclin 1-induced increase in TJ permeability and reduction in occludin level. Induction of autophagy also resulted in reduced beclin 1-occludin association. In mouse colon, beclin 1 colocalized with occludin on the epithelial membrane. Perfusion of mouse colon with beclin 1 peptide caused an increase in colonic TJ permeability that was prevented by in vivo induction of autophagy. These findings show that beclin 1 plays a constitutive, autophagy-independent role in the regulation of intestinal TJ barrier function via endocytosis of occludin. Autophagy terminates constitutive beclin 1 function in the TJ barrier and enhances the TJ barrier.
紧密连接(TJ)的功能障碍是炎症性肠病的一个关键致病因素。此前,我们已经表明,细胞存活机制自噬增强了肠道上皮 TJ 屏障功能。自噬相关蛋白-6(ATG6/Beclin 1)是自噬途径中的关键蛋白,也在胞吞途径中发挥作用。Beclin 1 在肠道 TJ 屏障中的组成性作用尚不清楚。在 Caco-2 细胞中,发现 Beclin 1 与 TJ 蛋白紧密连接蛋白 4(occludin)共免疫沉淀,并与膜上的 occludin 共定位。用 Beclin 1 肽[转激活调节蛋白(Tat)-Beclin 1]处理 Caco-2 细胞会降低 TJ 屏障功能。Beclin 1 的激活增加了 occludin 的内吞作用,并降低了总 occludin 蛋白水平。相比之下,Beclin 1 siRNA 转染增强了 Caco-2 TJ 屏障功能。在药理学和遗传自噬抑制研究中,发现 Beclin 1 在 TJ 屏障中的组成性功能是独立于自噬的。然而,饥饿或雷帕霉素诱导的自噬的从头诱导防止了 Tat-Beclin 1 诱导的 TJ 通透性增加和 occludin 水平降低。自噬的诱导也导致 Beclin 1-occludin 结合减少。在小鼠结肠中,Beclin 1 与上皮膜上的 occludin 共定位。用 Beclin 1 肽灌注小鼠结肠会增加结肠 TJ 通透性,而体内诱导自噬会阻止这种增加。这些发现表明,Beclin 1 通过 occludin 的内吞作用,在调节肠道 TJ 屏障功能方面发挥组成性、独立于自噬的作用。自噬终止 TJ 屏障中 Beclin 1 的组成性功能,并增强 TJ 屏障。